Please wait a minute...

中国生物工程杂志

CHINA BIOTECHNOLOGY
中国生物工程杂志  2020, Vol. 40 Issue (5): 40-47    DOI: 10.13523/j.cb.1912016
技术与方法     
易发生聚集的重组HBcAg病毒样颗粒的纯化*
谢航航1,2,白红妹1,2,叶超1,2,陈永俊1,2,袁明翠1,2,马雁冰1,2,**()
1 中国医学科学院北京协和医学院 医学生物学研究所 昆明 650118
2 云南省重大传染病疫苗研发重点实验室 昆明 650118
The Purification Procedure for the Recombinant HBcAg Virus-like Particle Easy to Generate Aggregation
XIE Hang-hang1,2,BAI Hong-mei1,2,YE Chao1,2,CHEN Yong-jun1,2,YUAN Ming-cui1,2,MA Yan-bing1,2,**()
1 Institute of Medical Biology,Chinese Academy of Medical Science&Peking Union Medical College,Kunming 650118, China
2 Yunnan Key Laboratory of Vaccine Research&Development on Severe Infectious Disease,Kunming 650118,China
 全文: PDF(1444 KB)   HTML
摘要:

目的:探索针对易发生聚集的重组HBcAg病毒样颗粒(VLP)的有效纯化方案。方法:培养的大肠杆菌经IPTG诱导重组HBcAg蛋白的表达,菌体超声破碎后的离心沉淀用含有不同浓度尿素的PBS缓冲液重悬溶解,经密度梯度离心并结合电镜观察对VLPs行为进行分析鉴定。以Sepharose 4 FF凝胶过滤层析在选定的尿素条件下纯化沉淀溶解液,纯化获得的目的蛋白进一步在含30%山梨醇的PBS中脱盐去除尿素。整个过程以SDS-PAGE及电镜进行各步骤样品中目的蛋白的分析。结果:含有1mol/L尿素的PBS缓冲溶液重悬超声沉淀,可有效溶解聚集的VLPs,在蔗糖密度梯度离心中显示典型HBcAg VLPs的行为,且电镜观察颗粒形态结构完整。经1mol/L尿素下凝胶过滤,VLPs进一步获得纯化。在脱尿素过程中流动相采用含30%山梨醇的PBS,有效避免了VLPs在尿素去除后重新聚集。结论:尿素与山梨醇的联合应用,为具有聚集现象的VLPs纯化制备提供了一种有效解决方案。

关键词: 病毒样颗粒纯化聚集尿素山梨醇    
Abstract:

Objective: To explore an effective purification procedure of recombinant HBcAg virus like particles (VLPs) that are prone to aggregation. Methods: The expression of recombinant HBcAg protein was induced by IPTG in cultured E. coli. The centrifugation precipitates of bacteria after ultrasonic fragmentation were resuspended and dissolved in PBS buffer with different concentrations of urea. The VLPs behavior was analyzed and identified by density gradient centrifugation and electron microscopy. The precipitate solution was purified by Sepharose 4 FF gel filtration chromatography under the selected urea conditions, and the purified target protein was further desalinate to remove urea with PBS containing 30% sorbitol. The entire process was analyzed by SDS-PAGE and electron microscopy. Results: The ultrasonic precipitates resuspensed with PBS buffer containing 1mol/L urea was effective dissolve the aggregated VLPs, which showed the behavior of typical HBcAg VLPs in sucrose density gradient centrifugation, and morphology and structure of the particales were complete by electron microscope. VLPs were further purified after 1mol/L urea gel filtration. In the process of urea removal, PBS containing 30% sorbitol was used as the mobile phase, which effectively avoided the reaggregation of VLPs after urea removal. Conclusion: The combined application of urea and sorbitol provides an effective solution for the purification and preparation of VLPs with aggregation phenomenon.

Key words: Virus-like particle (VLP)    Purification    Aggregation    Urea    Sorbitol
收稿日期: 2019-12-10 出版日期: 2020-06-02
ZTFLH:  Q939.4  
基金资助: * 国家自然科学基金面上项目(81773270);云南省应用基础研究重点项目(2016FA049)
通讯作者: 马雁冰     E-mail: may@imbcams.com.cn
服务  
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章  
谢航航
白红妹
叶超
陈永俊
袁明翠
马雁冰

引用本文:

谢航航,白红妹,叶超,陈永俊,袁明翠,马雁冰. 易发生聚集的重组HBcAg病毒样颗粒的纯化*[J]. 中国生物工程杂志, 2020, 40(5): 40-47.

XIE Hang-hang,BAI Hong-mei,YE Chao,CHEN Yong-jun,YUAN Ming-cui,MA Yan-bing. The Purification Procedure for the Recombinant HBcAg Virus-like Particle Easy to Generate Aggregation. China Biotechnology, 2020, 40(5): 40-47.

链接本文:

https://manu60.magtech.com.cn/biotech/CN/10.13523/j.cb.1912016        https://manu60.magtech.com.cn/biotech/CN/Y2020/V40/I5/40

图1  重组蛋白的表达鉴定
图2  以沉淀形式存在的重组蛋白在低浓度的尿素中以可溶性形式存在并为VLPs
溶解率和回收率 0.5mol/L 1mol/L 2mol/L 4mol/L
总沉淀(g) 0.162 0 0.162 0 0.162 0 0.162 0
剩余沉淀(g) 0.148 0 0.078 2 0.077 1 0.073 3
溶解沉淀(g) 0.014 0 0.083 8 0.084 9 0.088 7
沉淀溶解率(溶解沉淀/总沉淀×100%) 8.6% 51.7% 52.4% 54.8%
总蛋白质回收率[总蛋白质/(总蛋白质+沉淀蛋白质)×100%] 12.9% 80.2% 90.0% 92.1%
纯度(%) 41.5% 57.7% 55.9% 54.4%
目的蛋白回收率[总蛋白质×纯度/(总蛋白质+沉淀蛋白质) ×100%] 5.3% 46.3% 50.30% 50.10%
表1  不同浓度尿素溶解超声沉淀溶解率和蛋白质回收率
图3  凝胶过滤层析纯化重组蛋白
图4  不同保护剂溶解白色重组蛋白
重组蛋白溶解率 10%
山梨醇
20%
山梨醇
30%
山梨醇
5%
海藻糖
0.5mol/L
甘氨酸
0.5mol/L
NaCl
10%
甘油
10%
蔗糖
10%
葡萄糖
总沉淀(g) 0.031 0 0.031 0 0.031 0 0.031 0 0.031 0 0.031 0 0.031 0 0.031 0 0.031 0
剩余沉淀(g) 0.024 3 0.018 4 0.007 0.014 1 0.030 4 0.028 8 0.026 1 0.031 0 0.021 6
溶解沉淀(g) 0.005 7 0.012 6 0.023 0.015 9 0.000 6 0.001 2 0.004 9 0 0.008 4
溶解率(溶解沉淀/
总沉淀× 100%)
18.4% 40.6% 74.2% 51.3% 1.9% 3.8% 15.8% 0% 27.1%
表2  不同保护剂溶解白色重组蛋白溶解率
图5  30%山梨醇缓冲体系凝胶过滤脱尿素
[1] Zeltins A . Construction and characterization of virus-like particles: a review. Mol Biotechnol, 2013,53(1):92-107.
[2] Birnbaum F, Nassal M . Hepatitis B virus nucleocapsid assembly: primary structure requirements in the core protein. J Virol, 1990,64(7):3319-3330.
[3] Chu X, Li Y, Long Q , et al. Chimeric HBcAg virus-like particles presenting a HPV 16 E7 epitope significantly suppressed tumor progression through preventive or therapeutic immunization in a TC-1-grafted mouse model. Int J Nanomedicine, 2016,11:2417-2429.
[4] Long Q, Huang W, Yao Y , et al. Virus-like particles presenting interleukin-33 molecules: immunization characteristics and potentials of blockingIL-33/ST2 pathway in allergic airway inflammation. Hum Vaccin Immunother, 2014,10(8):2303-2311.
[5] Feng X, Liu H, Chu X , et al. Recombinant virus-like particles presenting IL-33 successfully modify the tumor microenvironment and facilitate antitumor immunity in a model of breast cancer. Acta Biomater, 2019,100:316-325.
[6] 黎奎, 孙鹏艳, 姚宇峰 , 等. 呈现埃博拉病毒包膜糖蛋白抗原表位重组病毒样颗粒的构建. 中国生物制品学杂志, 2017,30(4):351-356.
Li K, Sun P Y, Yao Y F , et al. Construction of recombinant virus-like particles embedding predicted antigenic epitopes of Ebola virus envolope glycoprotein. Chin J Biologicals, 2017,37(3):58-64.
[7] 孙文佳, 姚宇峰, 杨旭 , 等. 乙肝核心抗原病毒样颗粒呈现HPV 16L1抗原表位及特异抗体诱导. 中国生物工程杂志, 2017,37(3):58-64.
Sun W J, Yao Y F, Yang X , et al. Presentation of HPV 16L1 peptide-based HBcAg virus-like particle and Induction of specific antibody. China Biotechnology, 2017,37(3):58-64.
[8] Chu X, Li Y, Huang W , et al. Combined immunization against TGF-beta1 enhances HPV16 E7-specific vaccine-elicited antitumour immunity in mice with grafted TC-1 tumours. Artif Cells Nanomed Biotechnol, 2018,46(sup2):1199-1209.
[9] 孙鹏艳 . 小鼠VEGF/FGF-2疫苗构建与肿瘤干预及埃博拉病毒样颗粒构建. 昆明:昆明医科大学, 2017.
Sun P Y . The recombinant vaccines against mouse VEGF/FGF-2 and their potentials of interventing in tumor growth in mice. Kunming:Kunming Medical University, 2017.
[10] 李正丰, 王永录 . 保护剂及其在口蹄疫疫苗中的研究进展. 生物技术通报, 2009, (3):6-10.
Li Z F, Wang Y L . Study progress of the protectant in FMD vaccine. Biotechnology Bulltein, 2009, (3):6-10.
[11] Shi L, Sanyal G, Ni A , et al. Stabilization of human papillomavirus virus-like particles by non-ionic surfactants. J Pharm Sci, 2005,94(7):1538-1551.
[12] Ma Y, HayGlass K T, Becker A B , et al. Novel recombinant interleukin-13 peptide-based vaccine reduces airway allergic inflammatory responses in mice. Am J Respir Crit Care Med, 2007,176(5):439-445.
[1] 陈修月,周文锋,何庆,苏冰,邹亚文. 噬菌体Qβ病毒样颗粒的制备、纯化及鉴定[J]. 中国生物工程杂志, 2021, 41(7): 42-49.
[2] 张玲,曹小丹,杨海旭,李文蕾. 连续流层析技术在亲和层析中的应用及生产放大评估[J]. 中国生物工程杂志, 2021, 41(6): 38-44.
[3] 吕一凡,李更东,薛楠,吕国梁,时邵辉,王春生. LbCpf1基因的原核表达、纯化与体外切割检测 *[J]. 中国生物工程杂志, 2020, 40(8): 41-48.
[4] 蒋丹丹,王云龙,李玉林,张怡青. 含RGD修饰的病毒样颗粒递送ICG靶向肿瘤的研究 *[J]. 中国生物工程杂志, 2020, 40(7): 22-29.
[5] 位薇,常保根,王英,路福平,刘夫锋. Tau蛋白核心片段306~378的异源表达、纯化及聚集特性验证*[J]. 中国生物工程杂志, 2020, 40(5): 22-29.
[6] 刘珍珍,田大勇. 狂犬病疫苗蔗糖密度梯度离心纯化工艺开发 *[J]. 中国生物工程杂志, 2020, 40(4): 25-33.
[7] 朱彤彤,杨磊,刘应保,孙文秀,张修国. 辣椒疫霉PcCRN20-C蛋白的表达纯化及结晶 *[J]. 中国生物工程杂志, 2020, 40(1-2): 116-123.
[8] 王国强,于茵茵,曾华辉,王旭东,吴玉彬,尚立芝,李玉林,张怡青,张西西,张振强,王云龙. 基于MS2噬菌体病毒样颗粒的RT-PCR检测新型冠状病毒(SARS-CoV-2)质控品制备*[J]. 中国生物工程杂志, 2020, 40(12): 31-40.
[9] 潘炳菊,张宛怡,申会涛,刘婷婷,李中媛,罗学刚,宋亚囝. 甘露寡糖分离纯化研究进展*[J]. 中国生物工程杂志, 2020, 40(11): 90-95.
[10] 王彦伟,李鹏昊,梁严予,关洋,逄文强,田克恭. 猪圆环病毒2型病毒样颗粒的高效组装技术研究*[J]. 中国生物工程杂志, 2020, 40(11): 35-42.
[11] 谢玉锋,韩雪梅,路福平. 副干酪乳杆菌β-葡糖苷酶的表达、纯化及酶学性质研究 *[J]. 中国生物工程杂志, 2019, 39(5): 72-79.
[12] 付大伟,孙莹莹,徐伟. 融合蛋白NusA-hRI的高效异源表达、纯化及活性分析[J]. 中国生物工程杂志, 2019, 39(3): 21-28.
[13] 景佳美,徐欣,王敏,彭如超,施一. 沙粒病毒聚合酶C端的表达纯化与结晶条件筛选 *[J]. 中国生物工程杂志, 2019, 39(12): 18-23.
[14] 朱梦露,王雪雨,刘鑫,路福平,孙登岳,秦慧民. 一种新型亮氨酸5-羟化酶NmLEH的异源表达、纯化及酶学性质分析 *[J]. 中国生物工程杂志, 2019, 39(12): 24-34.
[15] 童超迪,吴坚平,杨立荣,徐刚. X射线衍射晶体法解析脱卤酶DehDIV-R结构的研究 *[J]. 中国生物工程杂志, 2018, 38(8): 19-25.